Theracryf

(TCF)
Sector: Pharmaceuticals & Biotechnology
0.23p
-0.02p -9.24
Last updated: 08:37:48

Director dealings

Trade date Director Volume / Price Trade value Trade type
No director deals found.

Major shareholders

Institution name Holding Percent
Northern Standard Limited 422,727,272 19.67%
TRACARTA LIMITED 422,727,272 19.85%
First Equity Limited 179,000,000 8.41%
T and I Limited 160,000,000 7.51%
Oberon Investments Limited 80,475,000 3.78%
Spreadex Ltd 80,009,545 3.72%
Andrew Leach 80,000,000 3.76%
Simon Gibeon 71,400,000 3.35%
Sarum Investment SICAV Plc 25,700,000 6.01%
Seneca Partners Limited 16,301,456 3.81%